Delivery Order SPE2DX22D0129-SPE2D826F0BBK
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $423,150 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive, non-set-aside award was issued on October 6, 2025, with an ultimate completion date of October 7, 2025. The contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $51,016.44 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract represents a child award under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $382,922.67 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a competitively awarded contract with no set-aside designation. The contract is a child order under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,248.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract, issued on November 2, 2025, with completion targeted for November 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and reflects AmerisourceBergen's established capability to supply critical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $9,106.42 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 10, 2025. The contract is a firm fixed-price delivery order with a ceiling value of $1,363.11 and an ultimate completion date of November 12, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,070.18 to AmerisourceBergen Drug Corp on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,277.24 to AmerisourceBergen Drug Corp on November 10, 2025, for pharmaceutical and medical supply products. This firm fixed-price delivery order, which is due for completion by November 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The award...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,865.12 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania. This non-competitive, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical,...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BBKDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $980,600.53 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its DLA Troop Support Medical IDC, AmerisourceBergen has demonstrated capability to fulfill diverse federal medical procurement requirements on a competitive basis, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the strategic vendors supporting this initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $980.6k | 11/10/25 |